Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy
Crossref DOI link: https://doi.org/10.1007/s10120-016-0594-4
Published Online: 2016-01-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Giampieri, Riccardo
Maccaroni, Elena
Mandolesi, Alessandra
Del Prete, Michela
Andrikou, Kalliopi
Faloppi, Luca
Bittoni, Alessandro
Bianconi, Maristella
Scarpelli, Marina
Bracci, Raffaella
Scartozzi, Mario
Cascinu, Stefano
Text and Data Mining valid from 2016-01-21